CXCL13 and squamous cell carcinoma: Analysis of serum CXCL13 levels in both subtypes of NSCLCs, squamous cell carcinoma (SCC) and adenocarcinoma (AC), showed that serum CXCL13 levels in ACs were higher than that in SCCs; this may be associated with patient prognosis (Singh et al., 2014).